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Background: Smoking prevalence is particularly high amongst more deprived social groups. This cross-sectional
study uses the Mosaic classification to explore socioeconomic variations in the delivery and/or uptake of cessation
interventions in UK primary care.
Methods: Data from 460,938 smokers registered in The Health Improvement Network between 2008 and 2010
were analysed. Logistic regression was used to calculate odds ratios for smokers having a record of receiving
cessation advice or a prescription for a cessation medication during the study period by Townsend quintile and for
each of the 11 Mosaic groups and 61 Mosaic types. Both of these measures are area-level indicators of deprivation.
Profiles of Mosaic categories were used to suggest ways to target specific groups to increase the provision of
cessation support.
Results: Odds ratios for smokers having a record of advice or a prescription increased with increasing Townsend
deprivation quintile. Similarly, smokers in more deprived Mosaic groups and types were more likely to have a
documented cessation intervention. The odds of smokers receiving cessation advice if they have uncertain
employment and live in social housing in deprived areas were 35% higher than the odds for successful
professionals living in desirable areas (odds ratio (OR) 1.35, 95% confidence interval (CI) 1.20-1.52; absolute risks
57.2% and 50.1% respectively), and those in low-income families living in estate-based social housing were 50%
more likely to receive a prescription than these successful professionals (OR 1.50, 95% CI 1.31-1.73; absolute risks
19.5% and 13% respectively). Smokers who did not receive interventions were generally well educated, financially
successful, married with no children, read broadsheet newspapers and had broadband internet access.
Conclusions: Wide socioeconomic variations exist in the delivery and/or uptake of smoking cessation interventions
in UK primary care, though encouragingly the direction of this variation may help to reduce smoking prevalence-
related socioeconomic inequalities in health. Groups with particularly low intervention rates may be best targeted
through broadsheet media, the internet and perhaps workplace-based interventions in order to increase the
delivery and uptake of effective quit support.* Correspondence: lisa.szatkowski@nottingham.ac.uk
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Smoking is the leading cause of preventable illness in
the UK [1], removing, on average, ten years from a
smoker’s life [2]. Whilst the population prevalence of
smoking has decreased over time, prevalence remains
high in more socially deprived groups [3,4]. In the UK in
2010, smoking prevalence was 28% in adults living in
households where the main earner worked in a manual
or routine occupation, compared to 13% where the main
earner was in a managerial or professional occupation
[5]. A recent study using the Mosaic geo-demographic
classification [6] (a measure of social group incorporat-
ing a wide range of individual and area-level characteris-
tics) demonstrated even wider disparities in smoking
prevalence; in some sectors of the population as many as
43% of adults smoked and in others the figure was as
low as 9% [7].
Approximately two-thirds of smokers want to quit
smoking, a figure similar across all social groups [5].
However, the most deprived smokers are three times less
likely to succeed in quitting than the least deprived (OR
2.5; 95% CI 1.4-4.7) [8]. Most previous studies have pri-
marily defined participants’ social group using occupa-
tional measures or area-level composite indicators such
as the Townsend score [9], which combines census data
on unemployment, car ownership, housing tenure and
overcrowding for output areas of approximately 150
houses. However, studies have highlighted a need to bet-
ter understand a range of other factors associated with
quitting [10,11], such as living in a smoke-free house-
hold [12], the area that the person lives [10], and sup-
port available from family and friends [13]. A more
nuanced understanding of the factors associated with
smoking and quitting behaviour may allow smoking
intervention programmes to better target individuals
and increase quit and quit success rates.
General practitioners (GPs) are well-placed to encour-
age and support smokers to quit by offering interven-
tions which have been proven effective and cost-effective
, such as delivering brief cessation advice [14] or offering
a prescription for nicotine replacement therapy (NRT)
[15], bupropion [16] or varenicline [17]. This study
builds on previous work [7] and uses Townsend quintile
alongside the Mosaic classification to explore which par-
ticular groups are most and least likely to be offered
and/or receive cessation support from a GP and to
suggest ways in which particular groups can be targeted
to increase the use of these effective cessation
interventions.
Methods
Data source
This study utilises data from The Health Improvement
Network (THIN), a dataset of medical records fromapproximately six million patients in 479 general prac-
tices throughout the UK [18]. THIN has previously been
shown to be demographically representative of the UK
population [19], and recorded prescribing rates of smok-
ing cessation medications are similar to dispensing rates
of these medications in pharmacies [20]. This study uses
data from 460,938 patients aged 16+ who were regis-
tered in THIN for a two year period from 1st July 2008
to 31st June 2010. All patients had one or more Read
codes [21] indicating they were a current smoker
recorded in their medical records during the study
period, and were therefore potentially eligible to receive
a smoking cessation intervention.
Read codes were used to identify patients with one or
more records of cessation advice in their medical notes
in the two year study period, and British National For-
mulary (BNF) [22] codes were used to ascertain patients
with one or more prescriptions for NRT, bupropion or
varenicline. The absence of a record does not necessarily
indicate that the intervention was not offered by the GP,
but perhaps only that it was offered by the clinician but
declined by the patient. Other data extracted were pa-
tients’ age, sex, Townsend quintile, Mosaic classification
and the presence of smoking-related chronic disease
(asthma, coronary heart disease, chronic obstructive pul-
monary disease, diabetes mellitus, hypertension, stroke
or transient ischaemic attack, psychoses and chronic
kidney disease). Patients were classified as having one of
these chronic conditions if they had a relevant Read
code in their medical notes before the start of, or during,
the study period (plus, in the case of asthma, a relevant
prescription indication treatment of active asthma dur-
ing, or within one year before, the start of the study).Mosaic
Mosaic is a geo-demographic profiling system, devel-
oped by Experian to help businesses understand their
customers [6]. Multivariate modelling is used to
group all of the UK’s 1.4 million postcodes into one
of 61 Mosaic types and 11 aggregated broader groups,
at the level of the full postcode (equating to 15
households on average across the country). Modelling
utilises over 400 variables from a range of sources –
54% of data are derived from the national Census,
whilst the remaining 46% include data from a range
of sources, such as the Mosaic UK Consumer Dynam-
ics Database, Experian Lifestyle Survey, Post Office
Address File, shopping centre data and Land Registry
data [6]. Due to commercial sensitivities some data
sources are not disclosed, and details of the modelling
procedure remain classified. Mosaic data were pro-
vided by Experian and anonymously linked to THIN
by EPIC, who provided the THIN data.
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The proportion of smokers who received cessation ad-
vice or a prescription for a smoking cessation medica-
tion was calculated for each quintile of Townsend score,
and each of the 11 Mosaic groups and 61 Mosaic types.
Logistic regression was used to calculate the odds of
smokers receiving these interventions, both unadjusted
and adjusted for age, sex and the presence of smoking-
related chronic conditions, and accounting for the clus-
tering of patients within practices using a cluster sandwich
estimator. In the case of medication prescribing, odds
ratios were additionally adjusted for whether the patient
had also received cessation advice, as arguably if the
smoker has received advice to quit they may be more
likely to be prescribed a smoking cessation aid. We used
likelihood ratio tests with a p value of < 0.05 to select
confounders for inclusion in the multivariable models.
Ethical approval for the use of the THIN data was granted
by the EPIC Scientific Review Committee, and all analyses
were completed using STATA version 11.0 (STATA Corp,
College Station, TX).
The Mosaic Multimedia Guide [23] was used to de-
scribe and compare the characteristics of the Mosaic
types found to be most and least likely to receive smok-
ing cessation advice and prescriptions for cessation med-
ications, including characteristics such as education,
benefits received, occupation, household income and ex-
posure to communications media such as newspapers,
internet access and time spent watching television.
Results
Of the 460,938 smokers included in this study, 51.3%
were male, their average age was 45 (range 16–102,
interquartile range 31–58) and 37.0% had one or more
smoking-related chronic conditions. A Townsend quin-
tile was available for 96.4% of smokers, and Mosaic clas-
sification for 80.6%. Overall, 53.1% of smokers received
advice to quit during the two year study period, and
16.5% of smokers received one or more prescriptions for
a smoking cessation medication.Table 1 Odds ratios for the association between Townsend q
(UK, 2008–10)
Townsend
Quintile
n Advice
% received OR* (95% CI) P-va
1 (Least deprived) 78,338 50.3 1.00
2 81,865 51.6 1.05 (1.01-1.08)
3 95,451 52.6 1.10 (1.05-1.15)
4 101,648 54.4 1.19 (1.12-1.26)
5 (Most deprived) 87,138 56.4 1.28 (1.19-1.37)
Missing 16,498 50.9 1.08 (0.98-1.18)
*adjusted for age, gender and chronic condition **adjusted for age, gender, chroni
OR = odds ratio; 95% CI = 95% confidence interval.Table 1 shows the proportion of smokers in each
Townsend quintile who received advice to quit or a
smoking cessation medication during the study period,
with odds ratios presented with reference to the least de-
prived group. Adjustment for confounders had no ap-
preciable effect on the magnitude and direction of the
unadjusted odds ratios, and so for brevity only adjusted
ratios are presented.
Table 1 shows a statistically significant increase in the
odds of smokers receiving both cessation advice and a
prescription for a smoking cessation medication with in-
creasing deprivation quintile. Patients in the most de-
prived Townsend quintile were 28% more likely to
receive advice compared to those least deprived group
(OR 1.28; 95% CI 1.19-1.37), and 16% more likely to re-
ceive a prescription (OR 1.16; 95% CI 1.05-1.28).
Table 2 shows the proportion of smokers by Mosaic
group who received advice to quit or a cessation medica-
tion. There is no natural ranking for Mosaic groups and
so odds ratios for both outcomes are presented relative
to group A (successful professionals living in desirable
areas).
Smokers in Mosaic group A (successful professionals
living in desirable areas) had the lowest unadjusted
prevalence of receiving a prescription for a smoking ces-
sation medication (13.0%), and the second lowest preva-
lence of receiving advice to quit (50.1%). Relative to this
baseline group, those in Mosaic group F (people with
uncertain employment living in social housing in de-
prived areas) were the most likely to receive advice (OR
1.35; 95% CI 1.20-1.52) and this group also were one of
the groups more likely to receive a prescription for a
smoking cessation medication. Those most likely to re-
ceive a prescription were smokers in group G (low-in-
come families living in estate based social housing), who
were 50% more likely to receive a prescription than
those in group A (OR 1.50; 95% CI 1.31-1.73).
Table 3 shows the proportion of smokers by Mosaic type
who received advice to quit or a smoking cessation medi-
cation. Given the large number of categories of Mosaicuintile and receiving smoking cessation interventions
Prescription
lue for trend % received OR** (95% CI) P-value for trend
- 14.7 1.00 -
< 0.001 15.5 1.05 (1.00-1.10) 0.001
16.7 1.13 (1.05-1.21)
17.6 1.18 (1.10-1.27)
17.5 1.16 (1.05-1.28)
0.132 16.7 1.12 (0.97-1.30) 0.111
c condition and advice given.
Table 2 Odds ratios for the association between Mosaic group and receiving smoking cessation interventions
(UK, 2008–10)
Mosaic group n Advice Prescription
% received OR* (95% CI) LRT P-value % received OR** (95% CI) LRT P-value
A (Successful professionals living in desirable
areas)
21,348 50.1 1.00 < 0.001 13.0 1.00 < 0.001
B (Young families living in new housing
estates)
43,373 50.2 1.10 (1.00-1.22) 17.4 1.32 (1.18-1.47)
C (Older families living in suburbs) 51,081 52.4 1.09 (1.00-1.19) 14.3 1.11 (1.00-1.22)
D (Close-knit inner city and manufacturing
town communities)
66,338 53.0 1.16 (1.05-1.28) 16.9 1.29 (1.14-1.47)
E (Young, educated and single individuals
living in areas of transient populations)
13,352 50.5 1.13 (0.95-1.35) 14.0 1.01 (0.87-1.18)
F (People with uncertain employment living in
social housing in deprived areas)
22,286 57.2 1.35 (1.20-1.52) 17.3 1.28 (1.12-1.47)
G (Low-income families living in estate based
social housing)
37,455 56.2 1.31 (1.17-1.47) 19.5 1.50 (1.31-1.73)
H (Upwardly mobile families living in former
social housing)
65,644 55.1 1.25 (1.13-1.37) 18.3 1.41 (1.26-1.58)
I (Older people with high care needs living in
social housing)
11,889 59.6 1.22 (1.09-1.36) 17.5 1.43 (1.26-1.63)
J (Independent older people with relatively
active lifestyles)
24,355 52.9 1.03 (0.94-1.14) 15.6 1.24 (1.10-1.40)
K (People living in rural areas far from
urbanisation)
14,415 49.9 0.99 (0.88-1.12) 17.0 1.35 (1.16-1.57)
Missing 89,402 52.1 1.12 (0.97-1.29) 15.5 1.18 (0.99-1.40)
*adjusted for age, gender and chronic condition **adjusted for age, gender, chronic condition and advice given.
OR = odds ratio; 95% CI = 95% confidence interval.
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deprivation, odds ratios have been calculated using the
type with the lowest crude prevalence of the outcome as
the baseline category. For brevity we have presented only
the 10% of Mosaic types with the lowest and highest ad-
justed odds ratios; results for all 61 Mosaic types can be
viewed in the accompanying Additional file 1: Table S1.
Smokers in Mosaic type E34 (halls of residence and
other buildings occupied mostly by students) had the low-
est unadjusted prevalence of receiving cessation advice
(41.5%), whereas smokers in type A01 (financially success-
ful people living in smart flats in cosmopolitan inner city
locations) had the highest (69.6%). After adjustment for
confounders, the odds of smokers classified as type A01
receiving cessation advice was 3.5 times higher than the
odds in group E34 (OR 3.56; 95% CI 1.28-9.12).
Conversely, smokers in Mosaic type A01 were least likely
to have received a prescription for a smoking cessation
medication, with just 6.9% doing so. Smokers in type K57
(communities of retired people and second home owners
in areas of high environmental quality) were most likely to
receive a prescription (OR 4.37; 95% CI 2.55-7.49).
Descriptive analysis of the characteristics of each
Mosaic type, using the Mosaic Multimedia Guide [23],
found that smokers least likely to receive cessation inter-
ventions were generally well educated, more often thannot to at least degree level, were employed in high in-
come jobs and were financially successful and secure,
and tended to be married but with no children. These
groups did the majority of their grocery shopping at su-
permarkets including Sainsbury’s, Waitrose and Marks
and Spencer, read broadsheet newspapers and specialist
magazines such as The Economist and Newsweek, and
had broadband internet access.
Those that were most likely to receive advice tended
to be single, lone parents, received more benefits, and
watched more television. Smokers most likely to receive
a prescription for a smoking cessation medication had a
low average annual income, were generally aged over 30
or were pensioners, had no children, and were in receipt
of government benefits. They also tended to have little
or no access to the internet.
Discussion and conclusions
This study has highlighted wide variations by socioeco-
nomic group, measured in three different ways, in the
odds of smokers receiving cessation advice or a prescrip-
tion for a cessation medication. Overall, our results tell a
consistent story – smokers in the more deprived social
groups are more likely to receive advice to quit or a medi-
cation prescription. However, the use of Mosaic classifica-
tion compared to Townsend quintile highlights a greater
Table 3 Odds ratios for the association between Mosaic type and receiving smoking cessation interventions (UK,
2008–10)
Advice Prescribing
Mosaic Types ordered
from lowest to
highest OR
N (%
received)
OR* (95%
CI)
LRT P-
value
Mosaic Types ordered
from lowest to
highest OR
N (%
received)
OR** (95%
CI)
LRT P-
value
E34 (Halls of residence
and other buildings
occupied mostly by
students)
393
(41.5)
1.00 < 0.001 A01 (Financially
successful people living
in smart flats in
cosmopolitan inner
city locations)
375
(6.9)
- < 0.001
K61 (Low income
farmers struggling on
thin soils in isolated
upland locations)
725
(46.6)
1.15 (0.86-1.53) E29 (Economically
successful singles living
in privately rented inner
city flats)
1,583
(9.9)
1.56 (1.13-2.17)
A03 (Successful
managers living in
large housing in
outer suburbia)
2,651
(48.0)
1.17 (0.86-1.59) A03 (Successful
managers living in large
housing in outer
suburbia)
2,651
(9.5)
1.75 (0.96-3.21)
A04 (Financially secure
couples, many close to
retirement, living in
desirable suburbs)
2,306
(49.8)
1.20 (0.91-1.58) C20 (Successful
members of the Asian
community living in
suburbs)
3,585
(10.7)
1.84 (1.08-3.14)
K57 (Communities of
retired people and
second home owners
in areas of high
environmental quality)
784
(49.1)
1.22 (0.91-1.65) A02 (Highly educated
senior professionals
mainly working in
media, politics and law)
1,537
(11.2)
2.02 (1.25-3.26)
A02 (Highly educated
senior professionals
mainly working in
media, politics and law)
1,537
(47.8)
1.22 (0.86-1.74) F36 (High density social
housing with high
levels of diversity,
mainly in inner London)
2,983
(12.5)
2.09 (1.19-3.66)
D26 (Communities of
low paid factory
workers, many of
South Asian descent)
1,250
(55.4)
1.75 (1.36-2.25) G43 (Elderly, many in
poor health due to work
in heavy industry, in
low rise social housing)
13,334
(19.5)
3.67 (2.27-5.94)
F36 (High density social
housing with high
levels of diversity,
mainly in inner London)
2,983
(56.9)
1.76 (1.29-2.41) B08 (Families and singles
living in developments
built after 2001)
1,399
(19.7)
3.70 (2.27-6.03)
D27 (Second generation
settlers from diverse
communities living in
multi-cultural inner city
terraces)
5,177
(57.3)
1.80 (1.39-2.33) J56 (Neighbourhoods
with retired people and
transient singles, working
in the health industry)
1,652
(18.6)
3.71 (2.19-6.29)
F38 (Singles, childless
couples and elderly,
living in high rise
social housing)
1,178
(61.4)
1.86 (1.45-2.39) G41 (Families, many of
which are single parent,
living in deprived social
housing on the
edge of regional areas)
7,515
(20.4)
3.73 (2.31-6.03)
F40 (Older tenements of
small private flats, often
occupied by highly
disadvantaged individuals)
2,627
(61.4)
2.10 (1.52-2.92) I50 (Elderly receiving
care in homes or
sheltered
accommodation)
3,551
(18.0)
3.78 (2.32-6.15)
A01 (Financially successful
people living in smart flats
in cosmopolitan inner city
locations)
375
(69.6)
3.56 (1.28-9.12) K57 (Communities of
retired people and
second home owners
in areas of high
environmental quality)
784
(21.1)
4.37 (2.55-7.49)
*adjusted for age, gender and chronic condition **adjusted for age, gender, chronic condition and advice given.
OR = odds ratio; 95% CI = 95% confidence interval.
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proportion of smokers receiving these interventions, and
enables identification of particular types of people who do
not fit the general pattern.
Our findings concur with previous research showing
that those in more deprived socioeconomic groups are
more likely to receive advice to quit smoking from their
GP [13,24], perhaps suggesting that primary care health
professionals are making a specific effort to target these
groups in an attempt to reduce smoking-related inequal-
ities. In addition, more deprived smokers may be more
likely to want to receive advice on how to quit [24], and
GPs may simply be responding to their patients’ wishes.
However, analysis by Mosaic type suggests that some
more deprived social groups, such as type K61 (low in-
come farmers struggling on thin soils in isolated upland
locations), are amongst the least likely to receive cessa-
tion advice. This perhaps supports the persistence of the
‘inverse care law’, whereby good quality healthcare ser-
vices are least accessible to those who most need them
[25], and demonstrates the potential utility of Mosaic to
identify deviations from the general underlying pattern.
That more deprived groups are the most likely to re-
ceive a prescription for a smoking cessation medication
may simply reflect their potential eligibility to receive
free National Health Service (NHS) prescriptions (sav-
ing, at the time of writing, £7.85 per dispensed item in
England). However, in Wales, where prescriptions have
been free since April 2007, patterns of prescribing by so-
cioeconomic group appear similar to those reported here
for the whole of the UK (though the relatively small
number of Welsh practices contributing data to THIN
limits the power to detect significant differences). It is
possible that those who are not receiving a prescription
from their GP are buying NRT elsewhere; NRT is avail-
able off-the-shelf in pharmacies and supermarkets, and
sales here account for approximately half of all NRT use
[26]. Bupropion and varenicline must be prescribed and
are not available elsewhere. Though prescribing of bu-
propion is very low (just 0.7% of smokers were pre-
scribed the drug in the two year study period) and there
is limited power to compare prescribing across Mosaic
groups and types, analysis of varenicline prescribing pat-
terns suggests that the findings reported here are not
only a reflection of less deprived groups buying NRT
elsewhere. More affluent Mosaic groups, including
group A (Successful professionals living in desirable
areas) and E (Young, educated and single individuals liv-
ing in areas of transient populations) were least likely to
be prescribed varenicline, in line with the pattern of pre-
scribing of cessation medications overall.
Frequency of consultation with a GP is known to vary
by socioeconomic status; in Great Britain adults who are
either employed or currently unemployed consult with aGP approximately four times per year, whereas the eco-
nomically inactive consult seven times per year [27]. A
higher consultation frequency in the most deprived
groups may increase the number of opportunities for a
GP to deliver a cessation intervention, contributing to
the higher rates of intervention reported here. Data on
consultation rates in THIN patients were not available
to us and thus we were not able to take variations into
account in our analyses.
To our knowledge this is the first study to investigate
variations in the delivery of smoking cessation interven-
tions using Mosaic as a measure of socioeconomic sta-
tus, and the first using such a large database of patient
records. The large dataset affords the power to compare
the delivery of cessation interventions in multiple sub-
groups, though in the case of Mosaic it is not immedi-
ately obvious which category to use as the baseline for
comparisons. Our use of the group and type with the
lowest prevalence of receiving advice and prescribing
will serve to maximise the difference in odds ratios be-
tween categories, though we feel this is appropriate to
highlight the extremes of intervention prevalence identi-
fied using Mosaic. Given that the prevalence of cessation
intervention is relatively high there may be some dis-
crepancy between our odds ratios and the relative risk.
However, this is unlikely to materially change the con-
clusions of our study [28]. Confidence in Mosaic is lim-
ited by the lack of available information about how the
classification system is derived, and the large number of
Mosaic types means the indicator may be quite cumber-
some to use as a measure of socioeconomic status in
statistical models or in public health planning. Care
must also be taken to avoid the ecological fallacy; Mo-
saic is an area-level measure, derived at the level of post-
code areas representing approximately 15 households,
and thus the characteristics of a Mosaic group or type
will not apply to all people in that group.
That smokers in more deprived groups are more likely
to receive a cessation intervention may help to reduce the
smoking-related socioeconomic inequalities in health
which result from the higher smoking prevalence in these
groups. However, overall just 53.1% of smokers were ad-
vised to quit and only 16.5% were prescribed a cessation
medication during the two year study period; these pro-
portions highlight room for improvement across all social
groups to ensure all smokers receive these effective inter-
ventions. The profiles of each Mosaic type provided by
Experian suggest ways in which specific groups could be
targeted to increase the delivery and uptake of effective in-
terventions. The generally-successful groups who were
least likely to receive smoking cessation advice or a pre-
scription for a cessation medication could perhaps best be
targeted through media such as the internet or in broad-
sheet newspapers and specialist magazines; television
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light viewers. Workplace-based interventions may also be
an effective way to reach these groups [29], who are gener-
ally all in employment. Further work is warranted to
understand the barriers preventing the most financially
and socially successful groups accessing the cessation in-
terventions available through primary care, or the GP-
level factors limiting the delivery of interventions to
smokers in these groups. It is encouraging that the higher
prevalence of cessation intervention in the more deprived
social groups is unlikely to contribute to a widening of
health inequalities. The use of Mosaic as illustrated here
demonstrates the potential to market cessation interven-
tions appropriately in different types of smokers in order
to increase the overall rate of intervention as well as that
in specific groups.Additional file
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